University of Minnesota. Driven to Discover.
Barriers in many countries limit treatment options and prevent people from getting the antibiotics they need.
The antibiotic market is broken, one expert said. "Policymakers must take this as a clarion call to act now."
Antibiotics were offered for 91% of UTI patients, but only 36% had clinical or lab evidence of one.
MDRO contamination rates ranged from 11.9% to 28.5% across 6 facilities.
Though success has been shown in only 2 patients, recruitment of more patients is under way.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.